Allan Kermode

Allan Kermode is a Clinical Professor of Neurology at The University of Western Australia (UWA) and Adjunct Professor of Neuroimmunology at Murdoch University. He is the Director of the Demyelinating Diseases Centre at the Perron Institute and previously served as Head of Neurology at Sir Charles Gairdner Hospital. His affiliations include visiting roles at Sun Yat Sen University (China) and leadership positions in organizations like the Pan Asian Committee for Treatment and Research in Multiple Sclerosis.

Education: Graduated from UWA, awarded the Medicinae Studii Princeps (Australian Medical Association Gold Medal), and holds Fellowships from the Royal Australasian College of Physicians and Royal College of Physicians (London).

Research Focus: Multiple Sclerosis (MS), Neuroimmunology, clinical trials, neuroimaging, and disease pathogenesis. Key contributions include establishing a WA clinical database of 2,400+ MS patients and advancing global MS treatment guidelines.

Recent Articles: Focus on MS progression modeling, therapy prescribing patterns during pandemics, and diagnostic innovations in neuromyelitis optica spectrum disorders. His work emphasizes machine learning applications and standardized clinical metrics.

Awards: NHMRC CJ Martin Scholar, Australian Medical Association Gold Medal, and multiple international recognitions.

Grants & Projects: Current initiatives include pediatric MS prediction (WA Health) and immune target discovery (National MS Society). Past projects include MS drug trials and genetic consortium research (IMSGC).